GlassScriptPhysician profile
Jason A Cheney
NPI 1275750325
$850.73
in general payments reported to CMS, 2019-2025
18 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.18 · 2020: $27.14 · 2022: $32.85 · 2023: $333 · 2024: $254 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $186.33 | 2022-2024 | Vraylar, Teflaro, Ubrelvy |
| Medtronic, INC. | $117.16 | 2023 | Abre |
| Astrazeneca Pharmaceuticals LP | $103.73 | 2019-2024 | Farxiga |
| Amgen INC. | $79.42 | 2024-2025 | Repatha, Otezla, Evenity |
| Novartis Pharmaceuticals Corporation | $58.67 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.56 | 2022-2025 | Jardiance, Tradjenta, Synjardy |
| Lilly USA, LLC | $54.34 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $27.14 | 2020 | |
| Astellas Pharma US INC | $27.08 | 2023-2024 | Veozah |
| E.R. Squibb & Sons, L.L.C. | $19.77 | 2025 | Camzyos |
| Otsuka America Pharmaceutical, INC. | $17.98 | 2025 | Rexulti |
| Viatris Specialty LLC | $16.88 | 2025 | Yupelri |
| Pfizer INC. | $15.43 | 2025 | |
| Exact Sciences Corporation | $14.56 | 2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $14.39 | 2023 | Xarelto |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $14.06 | 2025 | Acuson Sequoia Diagnostic Ultrasound System |
| Bayer Healthcare Pharmaceuticals INC. | $13.22 | 2024 | |
| Idorsia Pharmaceuticals US INC | $13.01 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Cheney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.